Start
Entdecken
nav.journalClub
Trends
Mehr
synapse
⌘+K
Sprache
Deutsch
Deutsch
3-O-Methyldopa, L-Dopa, and Trihexyphenidyl in the Treatment of Parkinson’s Disease | Synapse
March 3, 2026
3-O-Methyldopa, L-Dopa, and Trihexyphenidyl in the Treatment of Parkinson’s Disease
MM
Manfred D. Muenter
Mayo Clinic in Arizona
RD
Robert P. Dinapoli
Mayo Clinic
NS
Nansie S. Sharpless
See all
Key Points
L-Dopa significantly improves motor function in Parkinson's disease, often serving as the first-line treatment.
Trihexyphenidyl is effective for managing tremors, although it may cause side effects such as dry mouth.
3-O-methyldopa shows potential as an alternative treatment but requires further investigation for wider application.
Patient responses vary, indicating the need for personalized treatment strategies in managing Parkinson’s symptoms.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Muenter et al. (Thu,) studied this question.
synapsesocial.com/papers/69a761c6c6e9836116a2fd74
https://doi.org/https://doi.org/10.1016/s0025-6196(26)07959-0